Molecular epidemiology and virulence profiles of colistin-resistant Klebsiella pneumoniae blood isolates from the hospital agency "Ospedale dei Colli," Naples, Italy by Esposito, Eliana P. et al.
ORIGINAL RESEARCH
published: 16 July 2018
doi: 10.3389/fmicb.2018.01463
Frontiers in Microbiology | www.frontiersin.org 1 July 2018 | Volume 9 | Article 1463
Edited by:
Miklos Fuzi,
Semmelweis University, Hungary
Reviewed by:
Antonio Cannatelli,
University of Siena, Italy
Ákos Tóth,
National Public Health Institute (OKI),
Hungary
*Correspondence:
Francesco Imperi
francesco.imperi@uniroma1.it
Raffaele Zarrilli
rafzarri@unina.it
Specialty section:
This article was submitted to
Antimicrobials, Resistance and
Chemotherapy,
a section of the journal
Frontiers in Microbiology
Received: 07 March 2018
Accepted: 12 June 2018
Published: 16 July 2018
Citation:
Esposito EP, Cervoni M, Bernardo M,
Crivaro V, Cuccurullo S, Imperi F and
Zarrilli R (2018) Molecular
Epidemiology and Virulence Profiles of
Colistin-Resistant Klebsiella
pneumoniae Blood Isolates From the
Hospital Agency “Ospedale dei Colli,”
Naples, Italy. Front. Microbiol. 9:1463.
doi: 10.3389/fmicb.2018.01463
Molecular Epidemiology and
Virulence Profiles of
Colistin-Resistant Klebsiella
pneumoniae Blood Isolates From the
Hospital Agency “Ospedale dei
Colli,” Naples, Italy
Eliana P. Esposito 1, Matteo Cervoni 2,3, Mariano Bernardo 4, Valeria Crivaro 4,
Susanna Cuccurullo 4, Francesco Imperi 2,3* and Raffaele Zarrilli 1,5*
1Department of Public Health, University of Naples “Federico II,” Naples, Italy, 2Department of Biology and Biotechnology
“Charles Darwin,” Sapienza University of Rome, Rome, Italy, 3 Laboratory Affiliated to Istituto Pasteur Italia - Fondazione Cenci
Bolognetti, Rome, Italy, 4 Azienda Ospedaliera di Rilievo Nazionale (AORN) dei Colli, V. Monaldi Hospital, Naples, Italy, 5Centro
di Ingegneria Genetica (CEINGE) Biotecnologie Avanzate, Naples, Italy
Resistance to colistin is increasingly reported in Klebsiella pneumoniae clinical isolates.
The aim of this study was to analyze the molecular epidemiology and virulence profiles of
25 colistin-resistant K. pneumoniae blood isolates from the Hospital Agency “Ospedale
dei Colli,” Naples, Italy, during 2015 and 2016. Colistin MIC values of isolates ranged from
4 to 256 mg/L. The inactivation of the mgrB gene, encoding a negative regulator of the
PhoQ/PhoP signaling system, was the most frequent mechanism of colistin resistance
found in 22 out of 25 isolates. Of these, 10 isolates assigned to ST512 and PFGE types A
and A4 showed identical frameshift mutation and premature termination ofmgrB gene; 4
isolates assigned to ST258 and PFGE types A1 showed non-sense, frameshift mutation,
and premature termination; 3 and 1 isolates assigned to ST258 and PFGE A2 and ST512
and PFGE A3, respectively, had insertional inactivation of mgrB gene due to IS5-like
mobile element; 2 isolates assigned to ST101 and 1 to ST392 had missense mutations in
themgrB gene, 1 isolate assigned to ST45 showed insertional inactivation ofmgrB gene
due to IS903-like mobile element. phoQ missense mutations were found in 2 isolates
assigned to ST629 and ST101, respectively, which also showed a missense mutation in
pmrA gene. The mcr-1-2-3-4 genes were not detected in any isolate. Colistin-resistant
K. pneumoniae isolates showed variable virulence profiles in Galleria mellonella infection
assays, with the infectivity of two isolates assigned to ST45 and ST629 being significantly
higher than that of all other strains (P < 0.001). Interestingly, colistin MIC values
proved to make a significant contribution at predicting lethal doses values (LD50 and
LD90) of studied isolates in G. mellonella. Our data show that MgrB inactivation is a
common mechanism of colistin resistance among K. pneumoniae in our clinical setting.
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The presence of identical mutations/insertions in isolates of the same ST and PFGE profile
suggests the occurrence of clonal expansion and cross-transmission. Although virulence
profiles differ among isolates irrespective of their genotypes, our results suggest that high
colistin MIC could predict lower infectivity capability of the isolates.
Keywords: mechanisms of colistin-resistance, Klebsiella pneumonia, blood isolates, Galleria mellonella, virulence
profiles
INTRODUCTION
The occurrence of multidrug-resistant (MDR) or extensively
drug-resistant (XDR) Klebsiella pneumoniae infections (Bialek-
Davenet et al., 2014; Bradford et al., 2015; Holt et al., 2015; Pitout
et al., 2015; Cerqueira et al., 2017; Logan and Weinstein, 2017;
Otter et al., 2017) has favored the use of colistin-based regimens
as the most frequent therapeutic options (van Duin et al.,
2013). Unfortunately, resistance to colistin has been increasingly
reported in K. pneumoniae clinical isolates worldwide (Jeannot
et al., 2017; Poirel et al., 2017).
In K. pneumoniae, resistance to polymixins (polymyxin B
and colistin) is mainly due to modification of the lipid A
phosphate moieties of the lipopolysaccharide (LPS) with a sugar
or ethanolamine, which reduces the electrostatic interaction
between the cationic polymixins and anionic LPS (Poirel
et al., 2017). Molecular mechanisms responsible for colistin
resistance rely on mutations in the genes of two component
transcriptional regulatory systems PhoPQ and PmrAB, which
regulate the expression of pmrC gene that codes for the addition
of phosphoethanolamine and pmrHFIJKLM operon genes that
encode biosynthesis and lipid A transfer of 4-amino-4-deoxy-
L-arabinose (Cheng et al., 2015, 2016; Jayol et al., 2015; Wright
et al., 2015; Novovic´ et al., 2017; Poirel et al., 2017; Pragasam
et al., 2017). Moreover, mutations causing loss of function in
the MgrB protein, a negative feedback regulator of PhoPQ two
component regulatory system (Cannatelli et al., 2013, 2014, 2016;
Olaitan et al., 2014; Cheng et al., 2015; Giani et al., 2015; Poirel
et al., 2015; Arena et al., 2016; Jaidane et al., 2018) and mutations
in the crrB gene, which regulates the expression of pmrC gene
and pmrHFIJKLM operon through the PmrAB two component
system (Wright et al., 2015; Cheng et al., 2016; Jayol et al., 2017)
have been described. Also, the acquisition of plasmid-borne mcr
1.2 gene encoding a membrane-anchored enzyme which adds
phosphoethanolamine to lipid A has been recently reported in
K. pneumoniae (Di Pilato et al., 2016).
Worryingly, mounting evidence indicates that colistin
resistance caused by inactivation of the MgrB regulator is
not associated with fitness cost and decreased virulence of
K. pneumoniae (Cannatelli et al., 2015; Arena et al., 2016) and
is maintained in the absence of selective antimicrobial pressure
(Cannatelli et al., 2015). Also, it has been recently demonstrated
that inactivation of mgrB can stimulate K. pneumoniae virulence
by decreasing the expression of antimicrobial peptides and early
inflammatory response of the host (Kidd et al., 2017).
The aim of this study was to investigate the molecular
epidemiology and mechanism of colistin resistance a of 25
colistin-resistant K. pneumoniae blood isolates from the Hospital
Agency (HA) “Ospedale dei Colli,” Naples, Italy, during 2015 and
2016 and to assess the virulence profiles ofK. pneumoniae isolates
in a Galleria mellonella infection model.
MATERIALS AND METHODS
Setting and Design of the Study
The HA “Ospedale dei Colli” in Naples, Italy includes three
hospitals: “V. Monaldi Hospital,” which is a 580-bed tertiary-
care teaching hospital providing acute medical and surgical care
within cardiology, cardiothoracic surgery, and pneumology with
an active heart transplantation programme also; “D. Cotugno”
Hospital, which is a 209-bed hospital and is the referral
center for infectious diseases; Orthopedic Trauma Center
(OTC) Hospital, which is a 143-bed hospital and is the
referral center for orthopedic, neurology and neurosurgery.
The hospitals are provided with 6 intensive care units (ICU)s:
a neonatal ICU, a cardiac surgery ICU (CS-ICU), a post-
operative ICU (PO-ICU), and a cardiorespiratory ICU (CR-
ICU) in “V. Monaldi” Hospital, a medical-ICU (M-ICU) in
“D. Cotugno” Hospital, and a post-operative-ICU (PO-ICU)
in OTC Hospital. There is one microbiology laboratory that
processes samples from all three hospitals. Surveillance of
carbapenem resistant Enterobacteriaceae (CRE) in the HA
“Ospedale dei Colli” was performed as previously described
(Esposito et al., 2017). The present study analyzed 25 colistin-
resistant K. pneumoniae blood isolates from 25 patients who
were admitted to the HA “Ospedale dei Colli,” Naples from
January 2015 to September 2016. The first colistin-resistant
K. pneumoniae isolate from blood-culture was selected for each
patient.
Bacterial Strains Identification
The colistin-resistantK. pneumoniae strains were identified using
Vitek-2 and ID-GNB card for Gram-negative bacilli according to
manufacturer’s instructions (bioMérieux, Marcy l’Etoile, France).
Antimicrobial Susceptibility Testing
Antimicrobial susceptibilities were performed using the Vitek
2 system and the AST-GN card (bioMérieux, Marcy l’Etoile,
France). Values were interpreted according to breakpoint
table for interpretation of MIC values and zone diameters
(European Committee on Antimicrobial Susceptibility Testing,
2016). Colistin susceptibility assay was performed according to
recommendation of joint CLSI-EUCAST guidelines: http://www.
eucast.org/fileadmin/src/media/PDFs/EUCAST_files/General_
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documents/Recommendations_for_MIC_determination_of_
colistin_March_2016.pdf.
Genotype Analysis and Capsular Typing
Genotyping was performed using XbaI DNA macrorestriction,
pulsed-field gel electrophoresis (PFGE) with dendrogram
analysis as previously described (Del Franco et al., 2015).
Multilocus sequence typing (MLST) was performed as reported
in Diancourt et al. (2005) using primers and PCR conditions
available at http://bigsdb.pasteur.fr/klebsiella/primers_used.
html. Capsular typing was performed by PCR amplification
and sequencing of wzi gene as previously described (Brisse
et al., 2013). eBURST analysis of ST profiles and detection of
carbapenemase genes was performed as described previously
(Esposito et al., 2017).
Molecular Analysis of Colistin Resistance
The chromosomal DNA of clinical isolates was extracted using
DNeasy Blood & Tissue Kit according to the manufacturer’s
instructions (Qiagen, Milan, Italy). Analysis of plasmid-mediated
colistin resistance was performed by PCR amplification ofmcr-1,
mcr-2,mcr-3, andmcr-4 genes as described previously (Liu et al.,
2016; Xavier et al., 2016; Carattoli et al., 2017; Yin et al., 2017).
Chromosomally-encodedmodifications of the LPS were analyzed
through amplification and sequencing of themgrB, pmrA, pmrB,
crrB, phoP, and phoQ genes as described by Cannatelli et al.
(2013, 2014) and Jayol et al. (2014, 2015). The primers used are
shown in Table S1. DNA sequencing of PCR products and Basic
Local Alignment Search Tool (BLAST) analysis of nucleotide
and deduced protein sequences were performed as previously
described (Del Franco et al., 2015). Insertion sequences (ISs)
were identified using the ISfinder tool (https://www-is.biotoul.
fr/index.php). Complementation experiments for mgrB gene
were performed as described previously (Cannatelli et al., 2013)
with minor modification. K. pneumoniae transformants were
selected on Mueller-Hinton agar plates supplemented with 10
mg/L of tetracycline. MIC testing of the complemented strains
was performed in medium supplemented with 10 mg/L of
tetracycline, to avoid plasmid loss.
Galleria mellonella Infection Assays
Klebsiella pneumoniae strains were grown in MH to late
exponential phase. Cells were collected by centrifugation and
suspended in saline. Serial 10-fold dilutions of bacterial cell
suspensions in saline were injected into G. mellonella larvae as
described (Jander et al., 2000). Ten larvae were infected with
each infecting dose and 10 larvae were injected with sterile saline
as negative control. Larvae were incubated at 37◦C for 3 days
to monitor mortality. Each strain was tested in two or three
independent experiments, with at least four dilutions injected
in each experiment. Dose-dependent survival curves and lethal
doses 50 and 90% (LD50 and LD90, respectively) were determined
using the GraphPad Prism software as previously described
(Antunes et al., 2011). For each isolate, the results obtained with
the infecting doses corresponding to about 106 and 105 cells in
the two or three independent assays were also pooled to generate
Kaplan-Meier survival curves using GraphPad Prism.
Statistical Analysis
Statistical analysis of Kaplan-Meier survival curves was
performed with the Log-rank (Mantel-Cox) Test using GraphPad
Prism. Linear regression analysis of colistin MIC and LD50/LD90
values was performed by means of SPSS v. 20.0 (Chicago,
IL, USA). P-values < 0.05 were considered to be statistically
significant.
Nucleotide Sequence Accession Numbers
Nucleotide sequences ofmutatedmgrB and phoQ genes described
in this work have been deposited in GenBank under accession
numbers MG210951-MG210955 and MG214776-MG214777.
Ethics Statement
The study has been evaluated by the local Ethics committee
(Comitato Etico Università degli Studi della Campania
“Luigi Vanvitelli” Azienda Ospedaliera Universitaria “Luigi
Vanvitelli”—HA “Ospedali dei Colli”) (protocol number
52/2018). Patients included in the study were anonymized,
no written informed consent was acquired because of the
retrospective nature of the study.
RESULTS
Molecular Epidemiology of
Colistin-Resistant K. pneumoniae in the
HA “Ospedale dei Colli,” Naples, Italy
An increase of colistin-resistant K. pneumoniae clinical isolates
was observed in the HA “Ospedale dei Colli” during 2015
and 2016 with a prevalence of colistin-resistant K. pneumoniae
isolates over total K. pneumoniae isolates of 0.15. A total of
25 isolates from blood cultures were retrospectively collected
from 25 patients hospitalized in MS- ICU (11) and IDD (2)
of “D. Cotugno” hospital; CR-ICU (5), CS-ICU (4), and R-
ICU (2) of “V. Monaldi” hospital; PO-ICU (1) of OTC hospital
(Figure 1 and Table S2). Colistin resistance was detected in
initial K. pneumoniae isolates from 18 of the 25 patients, while
7 patients showed initial colistin-susceptible K. pneumoniae
isolate with a subsequent colistin-resistantK. pneumoniae isolate.
K. pneumoniae isolates showed a MDR phenotype. In particular,
all isolate were resistant to colistin and beta-lactam/beta-
lactamase inhibitor combinations (clavulanic acid/amoxicillin,
piperacillin/tazobactam); all isolates but one were resistant to
third and fourth generation cephems; 21 isolates were resistant
to imipenem and meropenem; 22 isolates were resistant to
ertapenem; all isolates but one were resistant to ciprofloxacin;
23 and 18 isolates were resistant to gentamicin and amikacin,
respectively; 23 isolates were resistant to tigecycline and
trimethoprim-sulfamethoxazole; 19 isolates were resistant to
fosfomycin. Colistin MIC values ranged from 4 to 256 mg/L
values (Table 1 and Table S2).
To investigate whether the increase in colistin-resistant
K. pneumoniae isolates in the HA “Ospedale dei Colli” was
due to the spread of epidemic strains, the 25 colistin-resistant
K. pneumoniae isolates from the HA “Ospedale dei Colli” and
2 colistin-susceptible K. pneumoniae reference isolates were
genotyped (isolates 8 and 17 inDel Franco et al., 2015).Molecular
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FIGURE 1 | Genotypic analysis of colistin-resistant K. pneumoniae isolates in the HA “Ospedale dei Colli,” Naples. Dendrogram analysis of K. pneumoniae isolates
from HA “Ospedale dei Colli,” Naples. Percentage of similarity and sizes in kilobases (kb) of lambda DNA molecular mass markers are indicated. Isolate number,
isolation date, hospitals, wards, PFGE type, MLST (ST and CC), wzi gene, and colistin MIC values are also shown. PFGE, pulsed-field gel electrophoresis; MLST,
multilocus sequence typing; ST; sequence type; CC, clonal complex.
TABLE 1 | Antimicrobial susceptibility profiles of the 25 colistin-resistant
K. pneumoniae strains included in the study.
Antimicrobial MICa (mg/liter)
MIC50 MIC90 Range
Amoxicillin-clavulanic acid >32 >32 16–>32
Piperacillin-tazobactam >128 >128 32–>128
Ceftazidime >64 >64 ≤1–>64
Cefotaxime >64 >64 ≤1–>64
Cefepime >64 >64 ≤1–>64
Imipenem >16 >16 ≤0.25–>16
Meropenem >16 >16 ≤0.25–>16
Ertapenem >8 >8 ≤0.5–>8
Amikacin >64 >64 ≤2–>64
Gentamicin 4 >16 ≤1–>16
Ciprofloxacin >4 >4 ≤0.25–>4
Tigecycline 4 >8 ≤0.5–>8
Fosfomycin 128 >256 ≤16–>256
Trimethoprim-sulfamethoxazole >320 >320 ≤20–>320
Colistin 128 256 4–256
aMIC, minimal inhibitory concentration.
typing using PFGE and dendrogram analysis identified 6 types,
which we named from A to F, which differed in migration of
more than 6 DNA fragments and showed a similarity of <80%
at dendrogram analysis. PFGE types A and B could be further
classified into 5 (A1–A5) and 2 (B1–B2) subtypes, respectively,
which showed one-fragment to five-fragment variation in
the macro-restriction pattern and a similarity of >80% at
dendrogram analysis. Of 25 colistin-resistant K. pneumoniae
isolates, 9 isolates showed PFGE type A; 4, 3, 1, and 1 isolates
showed PFGE types A1, A2, A3, and A4, respectively; 2 isolates
showed PFGE types B and B1; 2 isolates PFGE type D; three
sporadic isolates showed PFGE types C, E, or F. The two colistin-
susceptible isolates were assigned to PFGE types A5 and B2
(Figure 1). MLST analysis assigned PFGE types A, A3, A4, and
A5 to ST512; PFGE types A1 and A2 to ST258; PFGE types
B and B1 to ST101, PFGE type B2 to ST1685; PFGE type C
to ST392; PFGE type D to ST629; PFGE types E and F to
ST449 and ST45, respectively. As ST512 and ST1685 represent
single locus variants of ST258 and ST101, respectively, eBURST
analysis clustered ST258 and ST512 in clonal complex (CC) 258,
while ST101 and ST1685 in CC101 (Figure 1). Capsular typing
identified wzi allele 154 for isolates assigned to ST258 and ST512,
wzi allele 137 for isolates assigned to ST101 and ST1685, wzi allele
485 for isolates assigned to ST629, wzi alleles 37, 101, and 187
for isolates assigned to ST449, ST101, and ST392, respectively
(Figure 1). The screening for carbapenemases revealed that
all colistin-resistant isolates belonging to CC258 (ST512 and
ST258) and isolates assigned to ST101/B and ST392/C were
KPC-3 producers, while the isolate assigned to ST101/B1 and
one isolate assigned to ST629/D were VIM-1 producers. No
carbapenemase genes were found in isolates assigned to ST445/E
and ST45/F and in one of the isolates assigned to ST629/D
(Table 2).
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TABLE 2 | Molecular mechanisms of colistin-resistance in 25 K. pneumoniae blood isolates from HA “Ospedale dei Colli,” Naples.
Strain Genotype Carbapenemase Colistin MICa mgrBb PhoQc CrrBd PmrAc PmrBc
1 ST258/A2 KPC-3 8 Insertional inactivation, IS5-like
element at nt 75 (FW)
WT
2 ST629/D VIM-1 16 WT D150Ge L296Qf WT R256Ge
3 ST101/B KPC-3 256 t95g (V32G) D150Ge
W215G
– A217V WT
4 ST258/A2 KPC-3 8 Insertional inactivation, IS5-like
element at nt 75 (FW)
WT
5 ST629/D – 256 WT D150Ge
L257P
Q287K
L296Qf
WT WT
6 ST45/F – 64 Insertional inactivation, IS903 element
at nt 69 (FW)
–
7 ST101/B1 VIM-1 32 t50g (L17R) –
8 ST512/A4 KPC-3 256 1g19 (frameshift mutation) WT
9 ST392/C KPC-3 32 t139a (W47R) L296Qf
10 ST258/A2 KPC-3 4 Insertional inactivation, IS5-like
element at nt 75 (FW)
WT
11 ST512/A KPC-3 128 1g19 (frameshift mutation) WT
12 ST512/A KPC-3 128 1g19 (frameshift mutation) WT
13 ST258/A1 KPC-3 64 c88t (non-sense, premature
termination)
WT
14 ST512/A KPC-3 128 1g19 (frameshift mutation) WT
15 ST512/A KPC-3 128 1g19 (frameshift mutation) WT
16 ST258/A1 KPC-3 64 c88t (non-sense, premature
termination)
WT
17 ST512/A3 KPC-3 128 Insertional inactivation, IS5-like
element at nt 75 (FW)
WT
18 ST258/A1 KPC-3 64 c88t (non-sense, premature
termination)
WT
19 ST512/A KPC-3 256 1g19 (frameshift mutation) WT
20 ST449/E – 16 WT D150Ge – WT WT
21 ST512/A KPC-3 256 1g19 (frameshift mutation) WT
22 ST512/A KPC-3 256 1g19 (frameshift mutation) WT
23 ST258/A1 KPC-3 64 c88t (non-sense, premature
termination)
WT
24 ST512/A KPC-3 256 1g19 (frameshift mutation) WT
25 ST512/A KPC-3 256 1g19 (frameshift mutation) WT
aColistin MICs are expressed as mg/L.
bNucleotide (nt) numbers indicate the positions of mutations or of the insertion sites of IS (insertion sequence)s; numbering refers to the coding sequence of the mgrB open reading
frame (ORF) of the colistin-susceptible K. pneumoniae KKBO-1 strain (GenBank accession no. AVFC00000000.1), considering number 1 as the first base of the GTG start codon;
amino acid changes in the deduced protein sequence are indicated in parenthesis. FW indicates that the transposase gene is in the same orientation as the mgrB gene. Wild type (WT)
indicates that the sequence of the mgrB ORF was identical to that of the colistin-susceptible K. pneumoniae KKBO-1 strain (Cannatelli et al., 2013). 1, deletion.
cPositions and amino acid substitutions in PhoQ, PmrA and PmrB deduced protein sequences respect to colistin-susceptible K. pneumoniae NUTH-K2044 strain (GenBank accession
no. AP006725.1) (Cheng et al., 2015) are shown.
dPositions and amino acid substitutions in the CrrB protein sequence with respect to the CrrB protein of the colistin-susceptible K. pneumoniae UHKPC27 strain (GenBank accession
no. APVR00000000.1) (Wright et al., 2015) are shown; the (–) symbol indicates that the crrB gene was not amplified with the primers used in this work.
eMutations that do not affect MIC of the colistin susceptible K. pneumoniae NUTH- K2044 strain (Cheng et al., 2015).
fMutation previously found in the colistin susceptible K. pneumoniae XH209 strain (Hua et al., 2014).
Based on PFGE and MLST typing data, four distinct epidemic
genotypes were identified in 2 or more than 2 colistin-resistant
K. pneumoniae isolates from patients in the HA “Ospedale
dei Colli,” which we named ST512/A, ST258/A1, ST512/A2,
and ST629/D. Molecular epidemiology of colistin-resistant
K. pneumoniae in different wards of the HA “Ospedale dei Colli”
showed that ST512/A genotype was isolated in 7 and 2 patients
from M-ICU and IDD wards of “D. Cotugno” hospital during
2015; ST258/A1 and ST258/A2 genotypes were isolated in 2,
2, and 2 patients from CR-ICU, R-ICU, and R-ICU wards of
“V. Monaldi” hospital during 2015 and 2016, respectively, and
1 patients from M-ICU of “D. Cotugno” hospital during 2016;
ST629/D genotype was isolated in 1 from M-ICU ward of “D.
Cotugno” hospital and 1 patient from CS-ICU ward of “V.
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Monaldi” hospital during 2016. Genotypes ST512/A3, ST512/A4,
ST101/B, ST101/B1 ST392/C, ST/449/E, and ST45/F were isolated
from single patients in different wards and were considered as
sporadic (Figure 1 and Figure S1).
Molecular Mechanisms of
Colistin-Resistance in K. pneumoniae
Blood Isolates From the HA “Ospedale dei
Colli,” Naples
In order to analyze the molecular mechanisms responsible
for colistin-resistance, the presence of mcr genes encoding
membrane-anchored enzymes which add phosphoethanolamine
to lipid A was investigated in all isolates. Because the mcr-1,
mcr-2, mcr-3, and mcr-4 genes were not detected in any isolate,
the presence of mutations in regulators of PhoQ/PhoP and
PmrA/PmrB signaling systems was investigated.
Mutations in the mgrB gene, which encodes a negative
regulator of the PhoQ/PhoP signaling system, were present
in 22 out of 25 isolates. In particular, identical small
deletion1g19, which causes frameshift mutation and premature
termination of MgrB (GenBank accession no. MG210954),
was found in 9 and 1 isolates assigned to ST512/A and
ST512/A4 genotypes, respectively; non-sense mutation c88t,
which caused premature termination of MgrB, was found in
4 isolates assigned to ST258/A1 genotype (GenBank accession
no. MG210955); missense mutations V32G (NCBI Reference
Sequence: WP_094312677.1), L17R (GenBank accession no.
MG210952), and W47R (GenBank accession no. MG210953)
were found in isolates assigned to ST101/B, ST101/B1, and
ST392/C genotypes, respectively (Table 2). The insertional
inactivation of the mgrB gene was detected in 5 isolates. IS5-like
mobile element at nt 75 of mgrB gene (GenBank accession no.
MG214776) was found in 3 and 1 isolates assigned to ST258/A2
and ST512/A3 genotypes, respectively. An IS903-like element
(97% identity to IS903) at nucleotide 69 of mgrB gene (Genbank
accession no. MG214777) was found in 1 isolate assigned to
ST45/F genotype. Two isolates assigned to ST629/D and 1 isolate
assigned to ST449/E carried a wild typemgrB gene (Table 2).
Missense mutations were also found in pmrA, pmrB, phoQ,
and crrB genes when compared to the genes present in colistin-
susceptible K. pneumoniae NUTH-K2044 strain (GenBank
accession no. AP006725.1) (Cheng et al., 2015). For PhoQ
deduced protein sequences, a common mutation D150G was
found in isolates assigned to ST629/D, ST101B-B1, and ST449/E
genotypes. This mutation has been previously described and
was not related with colistin resistance (Cheng et al., 2015).
The substitutions W215G (Genbank accession no. MG210951)
and L257P (NCBI Reference Sequence: WP_087760419.1) were
also found in isolates assigned to ST101/B and ST629/D
genotypes; however, no information is available about their
implication in colistin resistance. In pmrA, a mutation leading
to the substitution A217V was found in the isolate assigned to
ST101/B genotype. This mutation has been already reported in
K. pneumoniae (NCBI Reference Sequence: WP_032419166.1),
but there is no information regarding colistin-susceptibility of
the isolates. Finally, a mutation causing the substitution R256G
in PmrB, which has been previously demonstrated to not confer
colistin resistance (Cheng et al., 2015), was found in 1 isolate
assigned to ST629/D genotype.
The sequence of the signal-transducing histidine kinase of the
two-component regulatory system CrrAB was also investigated.
In accordance with previous data (Wright et al., 2015), the crrB
gene was found in 21 out of 25 isolates. Of these, 18 isolates
assigned to ST512/A-A3-A4 and ST258/A1-A2 genotypes had
CrrB identical to that of the colistin-susceptible K. pneumoniae
UHKPC27 strain (GenBank accession no. APVR00000000.1)
(Wright et al., 2015), while 2 and 1 isolates assigned to
ST629/D and ST392/C genotypes, respectively, carried amissense
mutation leading to L296Q substitution in the CrrB protein
sequence. This CrrB substitution has been described already in
colistin-susceptible K. pneumoniae XH209 strain (Hua et al.,
2014), suggesting that is not responsible for colistin resistance of
our isolates.
The above data indicate that MgrB inactivation was the most
commonmechanism of colistin resistance among K. pneumoniae
isolates. In support of this, complementation experiments
demonstrated that plasmid pACYC-mgrB, carrying WT mgrB
gene fused to its own promoter, but not the empty plasmid
pACYC184, was able to restore colistin susceptibility in selected
K. pneumoniae isolates showing either insertional inactivation
(isolates 1 and 17) or different mutations (isolates 3, 7, 16, and
22) in themgrB gene (Table 3).
Virulence Profiles of Colistin-Resistant
K. pneumoniae Isolates
In order to verify the effect of colistin resistance on pathogenicity,
we assessed the virulence profile of 16 colistin resistant
K. pneumoniae isolates, representative of all different genotypes
identified in our collection and of different levels of colistin
resistance for each genotype, and of the 2 colistin sensitive strains
in the insect G. mellonella, which has been extensively used as
TABLE 3 | Colistin MICs of selected K. pneumoniae isolates carrying either the
pACYC184 or the pACYC-mgrB plasmid.
Strain mgrB mutation Colistin MIC (mg/L)a
+ pACYC184 + pACYC-mgrB
1 Insertional inactivation,
IS5-like element at nt
75 (FW)
8 0.5
3 t95g (V32G) 256 1
7 t50g (L17R) 32 0.5
16 c88t (premature
termination)
64 0.5
17 Insertional inactivation,
IS5-like element at nt
75 (FW)
128 0.25
22 1g19 (frameshift
mutation)
128 0.5
aMIC assays were performed using Mueller-Hinton Broth II supplemented with 10 mg/L
of tetracycline.
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an infection model to investigate the pathogenic potential of
K. pneumoniae strains (Insua et al., 2013; McLaughlin et al., 2014;
Arena et al., 2016).
We generated dose-dependent survival curves for all isolates,
which allowed to determine their LD50 and LD90 values in
G. mellonella larvae (Table 4). High variability in the infectivity
of the different isolates in G. mellonella was observed, with
LD90 values ranging from few thousands of cells (isolate 6)
to more than 40 millions of cells (isolate 21) (Table 4). This
huge variability is however mainly related to the presence of a
couple of hyper-virulent strains (isolates 6 and 2), characterized
by LD90 values more than 100- or 10-fold lower than those of
all other isolates respectively, and an isolate (21) which showed
very low infectivity, with an LD90 value >5-fold higher than
those of all other isolates (Table 4). The median LD50 and
LD90 values for the remaining isolates were about 1.5 × 10
5
and 5 × 106 cells respectively, in line with previous reports
on the pathogenicity of different K. pneumoniae strains in G.
mellonella larvae (Insua et al., 2013; Wand et al., 2017). The
higher infectivity of the isolates 2 and 6 was also confirmed
by Kaplan-Maier survival curves generated with two different
infecting doses (about 106 and 105 cells; Figure 2 and Figure S2).
Indeed, larvae infected with these isolates died much faster as
compared to those infected with other K. pneumoniae isolates,
with survival curves at both infecting doses significantly different
from those obtained with all other strains (P < 0.001) (Figure 2
and Figure S2). A relationship was found between LD50 and
TABLE 4 | Lethal doses 50% (LD50) and 90% (LD90) in G. mellonella larvae for
the indicated K. pneumoniae strainsa.
Strainb Genotypec Colistin MICd LD50 LD90 R
2
6 ST45/F 64 5.98 × 102 2.21 × 103 0.988
2 ST629/D 16 8.56 × 103 3.51 × 104 0.964
3 ST101/B 256 1.98 × 104 4.84 × 105 0.807
8 ST512/A4 256 6.51 × 104 4.83 × 106 0.768
4 ST258/A2 8 7.18 × 104 1.71 × 106 0.659
10 ST258/A2 4 7.46 × 104 2.58 × 106 0.740
11 ST512/A 128 9.45 × 104 2.21 × 106 0.825
20 ST449/E 16 9.93 × 104 3.43 × 106 0.832
17 ST512/A3 128 1.02 × 105 3.57 × 106 0.822
19 ST512/A 256 1.35 × 105 2.82 × 106 0.749
26 ST1685/B2 0.125 2.29 × 105 4.99 × 106 0.702
7 ST101/B1 32 4.46 × 105 6.03 × 106 0.790
9 ST392/C 32 7.24 × 105 8.27 × 106 0.824
5 ST629/D 256 7.86 × 105 6.42 × 106 0.997
27 ST512/A5 0.125 8.46 × 105 5.32 × 106 0.970
1 ST258/A2 8 8.80 × 105 6.58 × 106 0.933
13 ST258/A1 64 1.01 × 106 7.58 × 106 0.940
21 ST512/A 256 2.91 × 106 4.24 × 107 0.893
aLD50, LD90, and R2-values were determined using the GraphPad Prism software and the
dose-dependent survival curves shown in the Figure S3. LD50 and LD90 are expressed
as number of viable cells.
bStrains have been ordered according to increasing LD50 values.
cST and PFGE profiles are shown.
dColistin MICs are expressed as mg/L.
LD90 values and colistin MIC values among isolates, those with
elevated colistin MIC values having higher LD50 and LD90 values
(Table 4). Although correlation coefficients were not significant,
simple regression analysis showed that colistin MIC values make
a significant contribution at predicting both LD50 and LD90
values, though the latter appears to be more affected. In detail,
colistin MIC accounts for 27.9% (F value 6.183, Sig. 0.024) and
42.7% (F value 11.937, Sig. 0.003) of LD50 and LD90 variations,
respectively.
DISCUSSION
In the present study, we analyzed the molecular epidemiology,
mechanism of resistance, and virulence profiles of colistin-
resistant K. pneumoniae blood isolates from HA “Ospedale dei
Colli,” Naples. Our data demonstrate the cross transmission and
clonal expansion of 4 epidemic genotypes in different patients
and wards: ST512/A genotype was isolated in M-ICU and
IDD wards of “D. Cotugno” hospital, ST258/A1 and ST258/A2
genotypes were isolated in CR-ICU, R-ICU and R-ICU wards of
“V. Monaldi” hospital and M-ICU of “D. Cotugno,” ST629/D
genotype in M-ICU ward of “D. Cotugno” hospital and CS-
ICU ward of “V. Monaldi” hospital. This is in agreement with
previous data reporting clonal expansion of K. pneumoniae
isolates assigned to CC258 in Italy and world-wide (Bialek-
Davenet et al., 2014; Gaiarsa et al., 2015; Giani et al., 2015; Conte
et al., 2016; Cerqueira et al., 2017). Of the 7 K. pneumoniae
sporadic isolates, 2 were assigned to the emerging epidemic
clonal lineage CC101 (Del Franco et al., 2015; Conte et al., 2016;
Novovic´ et al., 2017; Jaidane et al., 2018). In agreement with
previous data (Cannatelli et al., 2014; Jayol et al., 2014; Bradford
et al., 2015; Giani et al., 2015; Wright et al., 2015), 20 out of
25 colistin-resistant K. pneumoniae isolates were carbapenem-
resistant and KPC-3 producing, while 2 were VIM-1 producing
isolates.
Colistin-resistant K. pneumoniae was the initial isolate from
18 patients (72%), while isolates were initially colistin-susceptible
and subsequently colistin-resistant in 7 patients (28%). The
inactivation of MgrB, the negative regulator of the PhoQ/PhoP
signaling system, was found in 22 (88%) colistin-resistant
K. pneumoniae isolates from HA “Ospedale dei Colli” and was
caused by 7 different mechanisms of mgrB alterations. This is
consistent with a recent study showing that the emergence of
colistin-resistant K. pneumoniae in two England Hospitals was
due to the transmission among patients of two distinct genotypes
harboring three distinct mechanisms of colistin resistance (Otter
et al., 2017). In agreement with previous data (Cannatelli et al.,
2014; Olaitan et al., 2014; Giani et al., 2015; Poirel et al., 2015,
2017; Wright et al., 2015; Jaidane et al., 2018), a truncated MgrB
was generated by one single nucleotide deletion, which causes
frameshift mutation and premature termination in 10 isolates
assigned to ST512/A and ST512/A4 genotypes, or by non-sense
mutation c88t, which causes premature termination in 4 isolates
assigned to ST512/A1. Mutated MgrB was generated by 3 distinct
mutations in 3 isolates assigned to ST101/B, ST101/B1 and
ST392/C genotypes. The insertional inactivation of mgrB gene
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FIGURE 2 | Kaplan–Meier survival curves of G. mellonella larvae infected with (A) 1 (±0.26) × 105 or (B) 1 (±0.26) × 106 viable cells of the indicated K. pneumoniae
strains. For each strain, 20 or 30 larvae were infected in two or three independent assays, respectively. In both experiments, the infectivity of isolates 2 and 6 (green
and red lines, respectively) is significantly higher than that of all other strains (P < 0.001).
due to IS5-like or IS-903-like mobile elements was observed in
2, 1, and 1 isolates assigned to ST512/A2, ST512/A3, and ST45/F,
respectively, similarly to data reported in Cannatelli et al. (2013),
Olaitan et al. (2014), and Poirel et al. (2015). In particular, the
insertion of IS5-like mobile element at nt 75 ofmgrB gene was in
the same position to that found in K. pneumoniae KKBO-4 strain
(Cannatelli et al., 2013), suggesting the existence of a specific hot
spot for IS5 insertion in themgrB gene. The presence of identical
mgrB alterations in isolates from the same ward/hospital assigned
to the same ST and PFGE profile demonstrates the occurrence of
clonal expansion and cross-transmission of the colistin-resistant
isolates within hospitals. Allelic variants with respect to the genes
present in a colistin-susceptible K. pneumoniae reference strain
were also found for pmrA, pmrB, phoQ, and crrB genes in some
K. pneumoniae isolates described in this study; these variants
have been already described in the literature and proposed to be
not related with colistin resistance.
The above all data suggest that colistin-resistance in
K. pneumoniae isolates was caused by alterations identified in
the mgrB gene. In support of this, complementation with a wild
type mgrB allele successfully restored colistin susceptibility in
isolates havingmutations or insertional inactivation ofmgrB gene
(Table 3). In particular, colistin susceptibility was restored also
in isolate 3, which carries mutations in both mgrB and phoQ
genes, further confirming that resistance was mainly caused by
inactivation of MgrB. Notably, three isolates showed a wild type
mgrB gene and no mutations in the other colistin-resistance
related genes here analyzed, suggesting the presence of still-
unidentified mechanism(s) alternative to mutations of mgrB
gene.
We also demonstrate that colistin-resistant K. pneumoniae
blood isolates from HA “Ospedale dei Colli” showed high
variability in the infectivity in G. mellonella larvae, with up to 10-
fold differences in lethal dose values among isolates assigned to
the same ST and PFGE genotype and two hyper-virulent isolates
assigned to ST45 and ST629 having LD90 values more than 100-
or 10-fold lower than those of all other isolates, respectively. This
is consistent with previous studies showing that K. pneumoniae
has a high genome variability and a large accessory genome,
which includes virulence functions associated with invasive
disease in humans and antimicrobial resistance genes associated
with hospital-acquired infections (Bialek-Davenet et al., 2014;
Holt et al., 2015; Cerqueira et al., 2017). K. pneumoniae isolates
assigned to CC258 and to other STs associated with hospital-
acquired infections have acquired antimicrobial resistance genes
and are usually devoid of virulence genes (Bialek-Davenet
et al., 2014; Cerqueira et al., 2017), although the acquisition
of yersiniabactin has been observed in many isolates of the
epidemic KPC-producing CC258 (Holt et al., 2015). In further
agreement with our data, carbapenem-resistant K. pneumoniae
ST258 isolates associated with nosocomial infections exhibit
variability in the infectivity of G. mellonella and in other
virulence-associated traits (Diago-Navarro et al., 2014). Our
data also showed no significant reduction in the infectivity
in colistin-resistant isolates assigned to ST101 or ST258/ST512
genotypes with inactivation of the mgrB gene as compared to
their respective colistin susceptible isolates (26 and 27; Figure 2).
This is an agreement with previous studies showing that colistin
resistance caused by the inactivation of the MgrB regulator is
not associated with fitness cost and decreased virulence of ST258
KPC carbapenemase-producingK. pneumoniae (Cannatelli et al.,
2015; Arena et al., 2016). Our data are also in partial agreement
with a recent study showing that inactivation of MgrB actually
enhanced virulence of K. pneumoniae Kp52145 strain, serotype
O1:K2, belonging to the virulent CC65 (Kidd et al., 2017),
although it should be considered that, even when they belong
to the same ST and PFGE type, our clinical isolates are
not isogenic, and thus a direct causal relationship between
specific mutations and infectivity cannot be inferred. In this
regard, it is worth noting that another study indeed reported
that colistin-resistant K. pneumoniae strains carrying distinct
mutations in pmrB or mgrB genes were highly variable in
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their pathogenicity in the G. mellonella infection model (Wand
et al., 2017). Overall, all the above data strongly suggest that
the pathogenicity of K. pneumoniae isolates is independent of
specific colistin-resistance mechanisms and might be influenced
by variability in the genetic background of the different strains.
Finally, it is interesting to note that some isolates assigned
to the same genotype, carrying the same mutation in mgrB
and showing identical alleles for all the other colistin-resistance
related genes here investigated, showed variability in colistin
MIC values (Table 2), indicating that other, still-unidentified
genetic mechanisms likely contribute to the acquisition of high
levels of colistin resistance in mgrB defective backgrounds.
Notably, although we did not observe any significant correlation
between colistin-resistance mechanisms and virulence, in line
with previous reports (Wand et al., 2017), our data suggest that
the level of colistin MIC of K. pneumoniae isolates is predictive of
their lethality (LD50 and LD90 values) in G. mellonella. Indeed, in
our experimental setting high colistin MIC values are predictive
of lower virulence of the isolates, suggesting that genetic adaption
to high levels of colistin resistance could somehow impair
K. pneumoniae infectivity. Further studies using larger collections
of isolates, isogenic in vitro evolved colistin-resistant mutants
and/or different infection models are however required to verify
this hypothesis. Moreover, as whole genome sequencing has not
been performed in this study, at this stage we cannot rule out that
the acquisition of specific virulence-related gene(s) could partly
account for the different pathogenic behavior of our isolates.
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